IL133074A0 - Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione - Google Patents

Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione

Info

Publication number: IL133074A0
Authority: IL; Israel
Prior art keywords: thiazolidine; dione; pyridyl; ethoxy; benzyl
Prior art date: 1997-06-05

Application number

IL13307498A

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2001-03-19

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc

1998-06-02 Priority to IL16014498A priority Critical patent/IL160144A0/en

2001-03-19 Publication of IL133074A0 publication Critical patent/IL133074A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

IL13307498A 1997-06-05 1998-06-02 Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione IL133074A0 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
IL16014498A IL160144A0 (en)	1997-06-05	1998-06-02	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition
PCT/EP1998/003478 WO1998055122A1 (en)	1997-06-05	1998-06-02	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione

Publications (1)

Publication Number	Publication Date
IL133074A0 true IL133074A0 (en)	2001-03-19

Family

ID=26311662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL13307498A IL133074A0 (en)	1997-06-05	1998-06-02	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (en)
JP (1)	JP2001521553A (en)
KR (1)	KR20010013410A (en)
CN (3)	CN1526391A (en)
AP (1)	AP1214A (en)
AR (2)	AR015120A1 (en)
AU (1)	AU8215098A (en)
BG (1)	BG104048A (en)
BR (1)	BR9810405A (en)
CA (2)	CA2292629C (en)
CO (1)	CO4940400A1 (en)
DZ (1)	DZ2510A1 (en)
EA (1)	EA002384B1 (en)
GB (1)	GB9711683D0 (en)
HU (1)	HUP0004070A3 (en)
ID (1)	ID24264A (en)
IL (1)	IL133074A0 (en)
MX (1)	MXPA99011322A (en)
NO (2)	NO995938L (en)
NZ (2)	NZ523725A (en)
OA (1)	OA11306A (en)
PE (1)	PE78899A1 (en)
PL (1)	PL337201A1 (en)
SK (1)	SK164899A3 (en)
TR (2)	TR199902963T2 (en)
TW (1)	TW570797B (en)
UY (1)	UY25032A1 (en)
WO (1)	WO1998055122A1 (en)
ZA (2)	ZA984826B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20010040A1 (en)	1999-04-23	2001-03-10	Smithkline Beecham Plc	SALT POLYMORPH OF MALEIC ACID OF 5- [4- [2- (N-METHYL-N- (2-PYRIDYL) AMINO) ETHOXY] BENZYL] -THAZOLIDINE-2,4-DIONA
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
ATE246191T1 (en)	1999-04-23	2003-08-15	Smithkline Beecham Plc	POLYMORPHOUS OF 5-(4-(2-(N-METHYL-N-(2-PYRDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE MALEIC ACID SALT
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
AU2002350965A1 (en) *	2001-12-13	2003-06-23	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
DE06252444T8 (en) *	2006-05-09	2009-03-19	Teva Pharmaceutical Industries Ltd.	2-N- {5 - [[4- [2- (Methyl-2-pyridinylamino) -ethoxy] -phenyl] -methyl] -2,4-thiazolidinedione-succinic acid, method of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3856378T2 (en) *	1987-09-04	2000-05-11	Beecham Group P.L.C., Brentford	Substituted thiazolidinedione derivatives
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
WO1995021608A1 (en) *	1994-02-10	1995-08-17	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
KR19990036290A (en) *	1995-08-10	1999-05-25	로즈 암스트롱	Reduction of Exogenous Insulin Dosage in Non-insulin-Dependent Diabetic Patients
AU7604596A (en) *	1995-11-17	1997-06-11	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
EP0921798A1 (en) *	1996-07-12	1999-06-16	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 JP JP50158799A patent/JP2001521553A/en not_active Ceased
- 1998-06-02 SK SK1648-99A patent/SK164899A3/en unknown
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/en active Pending
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Application Discontinuation
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/en unknown
- 1998-06-02 IL IL13307498A patent/IL133074A0/en unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/en not_active Application Discontinuation
- 1998-06-02 EA EA199901116A patent/EA002384B1/en not_active IP Right Cessation
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/en unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 ID IDW991520A patent/ID24264A/en unknown
- 1998-06-02 PL PL98337201A patent/PL337201A1/en unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/en not_active Expired - Lifetime
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/en unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/en unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/en not_active IP Right Cessation
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/en active
- 1998-06-04 CO CO98031614A patent/CO4940400A1/en unknown
- 1998-06-04 AR ARP980102650A patent/AR015120A1/en not_active Application Discontinuation
- 1998-06-04 UY UY25032A patent/UY25032A1/en not_active IP Right Cessation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/en unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/en unknown
- 1998-06-04 AR ARP980102649A patent/AR008198A1/en not_active Application Discontinuation
- 1998-06-05 PE PE1998000466A patent/PE78899A1/en not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/en not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/en not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/en unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/en unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/en active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2001521553A (en)	2001-11-06
NO995938D0 (en)	1999-12-03
EA199901116A1 (en)	2000-06-26
PL337201A1 (en)	2000-08-14
AR015120A1 (en)	2001-04-18
BR9810405A (en)	2000-08-29
AP1214A (en)	2003-10-08
WO1998055122A1 (en)	1998-12-10
CN1430959A (en)	2003-07-23
CA2292629A1 (en)	1998-12-10
AU8215098A (en)	1998-12-21
ID24264A (en)	2000-07-13
PE78899A1 (en)	1999-10-22
CA2292629C (en)	2004-01-06
KR20010013410A (en)	2001-02-26
BG104048A (en)	2000-07-31
NZ513922A (en)	2001-09-28
ZA984826B (en)	1999-08-03
NZ523725A (en)	2004-09-24
CO4940400A1 (en)	2000-07-24
UY25032A1 (en)	1998-11-26
HUP0004070A2 (en)	2002-02-28
SK164899A3 (en)	2000-11-07
ZA9811572B (en)	1999-07-22
DZ2510A1 (en)	2003-01-25
TR199902963T2 (en)	2000-02-21
TR200002790T2 (en)	2001-11-21
CN1259050A (en)	2000-07-05
AP9901696A0 (en)	1999-12-31
EA002384B1 (en)	2002-04-25
TW570797B (en)	2004-01-11
NO995938L (en)	2000-02-02
CN1526391A (en)	2004-09-08
CN1112926C (en)	2003-07-02
HUP0004070A3 (en)	2002-03-28
GB9711683D0 (en)	1997-08-06
AR008198A1 (en)	1999-12-29
MXPA99011322A (en)	2004-12-02
OA11306A (en)	2003-10-22
EP0998284A1 (en)	2000-05-10
CA2333352A1 (en)	1998-12-10
NO20040738L (en)	2000-02-02

Publication	Publication Date	Title
IL151425A0 (en)	2003-04-10	Hydrochloride salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione
AU4600493A (en)	1994-06-16	Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl) -1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride
IL146111A0 (en)	2002-07-25	5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
PL341146A1 (en)	2001-03-26	Maleic 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolydin-2,4-dione salt hydrate as a pharmacological agent
HUP0004070A3 (en)	2002-03-28	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
IL155036A0 (en)	2003-10-31	Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and pharmaceutical compositions containing the same
AP2000001830A0 (en)	2000-06-30	Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
ZA984795B (en)	1999-01-04	New thiazolidinedione oxazolidinedione and oxadiazolidinedione derivatives
AU2002343036A1 (en)	2003-06-10	5-(4-(2-(n-methyl-n-(2-pyridyl)amido)ethoxy)benzyl)thiazolidine-2,4-dione and pharmaceutical compositions comprising the same
IL154724A0 (en)	2003-10-31	The hydrochloride salt of 5-[4- [2- (n-methyl-n- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
IL160144A0 (en)	2004-06-20	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
IL188116A0 (en)	2008-03-20	Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
HU9802874D0 (en)	1999-02-01	Process for making 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithiocarbazinate
GB0021784D0 (en)	2000-10-18	Novel pharmaceutical
AU6255001A (en)	2001-12-17	5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide as pharmaceutical
AU2002352481A1 (en)	2003-07-09	5- (4- (2- (n-methyl-n- (2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione nephtalenesulfonate salt and use against diabetes mellitus
IL166189A (en)	2005-07-25	5-{4-[2-(n-methyl-n-(2-pyridyl) amino) ethoxy] benzyl}-5-{1-[2, 4-dioxothiazolidine-5-yl]-1-[4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy) phenyl] methyl}-2,4-thiazolidinedione and tautomeric form, salt or solvate thereof
AU2002222305A1 (en)	2002-07-08	5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
SI1265893T1 (en)	2005-12-31	Hydrochloride salts of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione